This did go down for no reason. Investors feared the investigation may have implicated the company. In reality the company is the one that exposed the fraud to the SEC and is being unfairly punished. This should recover from the oversold condition but will be slower as more and more investors realize the company shouldn't be punished for doing the right thing. It is clear the quality of shareholders in the OTC are marginal as one past long panic sold and now downs the company on a daily basis. Delays happen regularly in pharmaceuticals and some of our delays were obvious change of direction for the better. I will end this with one thing that is sure to turn this company from a small unknown Israel company to the next well known high quality cannabis pharma and that is Dr. Oron Yacoby Zeevi. Watch and learn rookies!